University Health System
Welcome,         Profile    Billing    Logout  
 13 Trials 
33 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Blanco, Cynthia L
NCT02860702: Exclusive Human Milk Feeding in Infants With Single Ventricle Physiology

Completed
N/A
16
US
Human Milk Derived Fortifier, Human/Bovine Milk, Human/Formula Milk
The University of Texas Health Science Center at San Antonio, Prolacta Bioscience, Baylor College of Medicine, Children's Hospital Medical Center, Cincinnati, Columbia University, University of Oklahoma, Ann & Robert H Lurie Children's Hospital of Chicago, Cook Children's Medical Center, Children's Hospital of Orange County, University of Texas, University of Florida
Congenital Heart Defect
12/20
10/22
NCT05380401: Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants

Recruiting
N/A
328
US
Enfamil® DHA & ARA Supplement for Special Dietary Use, DHA/ARA Supplement
The University of Texas Health Science Center at San Antonio, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Premature
04/27
04/28
NCT04508348: Clinical Trial to Decrease Length of Stay in Infants With Neonatal Abstinence Syndrome With an Exclusive Human Milk Diet

Active, not recruiting
N/A
19
US
Human Milk, 100% Human Milk, Standard of Care, Mother's milk and/or formula
The University of Texas Health Science Center at San Antonio
Neonatal Abstinence Syndrome
03/25
03/25
Liss, Michael
S1802, NCT03678025: Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Recruiting
3
1273
Europe, US, RoW
Abiraterone, CB 7598, Bicalutamide, Casodex, Cosudex, ICI 176,334, ICI 176334, Degarelix, FE200486, Firmagon, Docetaxel, Docecad, RP56976, Taxotere, Taxotere Injection Concentrate, Flutamide, 4'-Nitro-3'-trifluoromethylisobutyranilide, Apimid, Cebatrol, Chimax, Cytomid, Drogenil, Euflex, Eulexine, Flucinom, Flucinome, Flugerel, Fluken, Flulem, FLUT, Fluta-Gry, Flutabene, Flutacan, Flutamex, Flutamin, Flutan, Flutaplex, Fugerel, Grisetin, Niftolide, Oncosal, Profamid, Propanamide, 2-Methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)-, Prostacur, Prostadirex, Prostica, Prostogenat, SCH 13521, Tafenil, Tecnoflut, Testotard, Goserelin Acetate, ZDX, Zoladex, Histrelin Acetate, Supprelin, Vantas, Leuprolide Acetate, A-43818, Abbott 43818, Abbott-43818, Carcinil, Depo-Eligard, Eligard, Enanton, Enantone, Enantone-Gyn, Ginecrin, LEUP, Leuplin, Leuprorelin Acetate, Lucrin, Lucrin Depot, Lupron, Lupron Depot, Lupron Depot-3 Month, Lupron Depot-4 Month, Lupron Depot-Ped, Procren, Procrin, Prostap, TAP-144, Trenantone, Uno-Enantone, Viadur, Nilutamide, Anandron, Nilandron, RU-23908, Orchiectomy, Castration, Male Castration, Male Gonadectomy, orchidectomy, Prednisone, .delta.1-Cortisone, 1, 2-Dehydrocortisone, Adasone, Cortancyl, Dacortin, DeCortin, Decortisyl, Decorton, Delta 1-Cortisone, Delta-Dome, Deltacortene, Deltacortisone, Deltadehydrocortisone, Deltasone, Deltison, Deltra, Econosone, Lisacort, Meprosona-F, Metacortandracin, Meticorten, Ofisolona, Orasone, Panafcort, Panasol-S, Paracort, PRED, Predicor, Predicorten, Prednicen-M, Prednicort, Prednidib, Prednilonga, Predniment, Prednisonum, Prednitone, Promifen, Servisone, SK-Prednisone, Quality-of-Life Assessment, Quality of Life Assessment, Radiation Therapy, Cancer Radiotherapy, Irradiate, Irradiated, irradiation, Radiation, Radiotherapeutics, RADIOTHERAPY, RT, Therapy, Radiation, Radical Prostatectomy, Prostatovesiculectomy, Triptorelin, 6-D-Tryptophan-LH-RH, 6-D-Tryptophanluteinizing Hormone-releasing Factor, AY-25650, CL-118,532, Decapeptyl, Detryptoreline
SWOG Cancer Research Network, National Cancer Institute (NCI)
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8
04/28
10/31
ERADICATE, NCT04484818: Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The Study

Active, not recruiting
3
27
US
Darolutamide, Antiandrogen ODM-201, BAY 1841788, BAY-1841788, BAY1841788, ODM 201, ODM-201, Goserelin Acetate, ZDX, Zoladex, Leuprolide Acetate, A-43818, Abbott 43818, Abbott-43818, Carcinil, Depo-Eligard, Eligard, Enanton, Enantone, Enantone-Gyn, Ginecrin, LEUP, Leuplin, Leuprorelin Acetate, Lucrin, Lucrin Depot, Lupron, Lupron Depot, Lupron Depot-3 Month, Lupron Depot-4 Month, Lupron Depot-Ped, Lutrate, Procren, Procrin, Prostap, TAP-144, Trenantone, Uno-Enantone, Viadur, Placebo Administration, Quality-of-Life Assessment, Quality of Life Assessment, Triptorelin, 6-D-Tryptophan-LH-RH, 6-D-Tryptophanluteinizing Hormone-releasing Factor, AY-25650, CL-118,532, Detryptoreline
ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI)
Prostate Carcinoma
12/25
05/28
INDICATE, NCT04423211: Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Recruiting
3
804
US
3-Dimensional Conformal Radiation Therapy, 3-dimensional radiation therapy, 3D Conformal, 3D CONFORMAL RADIATION THERAPY, 3D CRT, 3D radiotherapy, 3D-CRT, Conformal Therapy, Radiation Conformal Therapy, Radiation, 3D Conformal, Three dimensional external beam radiation therapy (procedure), Apalutamide, ARN 509, ARN-509, ARN509, Erleada, JNJ 56021927, JNJ-56021927, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, CT, CT Scan, tomography, Degarelix, FE200486, Firmagon, External Beam Radiation Therapy, Definitive Radiation Therapy, EBRT, External Beam Radiation, External Beam Radiotherapy, External Beam Radiotherapy (conventional), External Beam RT, external radiation, External Radiation Therapy, external-beam radiation, Radiation, External Beam, Teleradiotherapy, Teletherapy, Teletherapy Radiation, Fluciclovine F18, (18F)Fluciclovine, (18F)GE-148, 18F-Fluciclovine, [18F]FACBC, Anti-(18f)FABC, Anti-1-Amino-3-[18F]Fluorocyclobutane-1-Carboxylic Acid, Anti-[18F] FACBC, Axumin, Fluciclovine (18F), FLUCICLOVINE F-18, GE-148 (18F), GE-148 F-18, Goserelin Acetate, ZDX, Zoladex, Intensity-Modulated Proton Therapy, IMPT, Intensity-Modulated Radiation Therapy, IMRT, Intensity modulated radiation therapy (procedure), Intensity Modulated RT, Intensity-Modulated Radiotherapy, Radiation, Intensity-Modulated Radiotherapy, Leuprolide Acetate, A-43818, Abbott 43818, Abbott-43818, Carcinil, Depo-Eligard, Eligard, Enanton, Enantone, Enantone-Gyn, Ginecrin, LEUP, Leuplin, Leuprorelin Acetate, Lucrin, Lucrin Depot, Lupron, Lupron Depot, Lupron Depot-3 Month, Lupron Depot-4 Month, Lupron Depot-Ped, Lutrate, Procren, Procrin, Prostap, TAP-144, Trenantone, Uno-Enantone, Viadur, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron emission tomography (procedure), Positron Emission Tomography Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging, PT, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Relugolix, N-(4-(1-((2,6-Difluorophenyl)methyl)-5-((dimethylamino)methyl)-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno(2,3-d)pyrimidin-6-yl)phenyl)-N'-methoxyurea, Orgovyx, TAK 385, TAK-385, Stereotactic Body Radiation Therapy, SABR, SBRT, Stereotactic Ablative Body Radiation Therapy, Triptorelin, 6-D-Tryptophan-LH-RH, 6-D-Tryptophanluteinizing Hormone-releasing Factor, AY-25650, CL-118,532, Detryptoreline, Volume Modulated Arc Therapy, VMAT, Volumetric Modulated Arc Therapy (procedure)
ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI)
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma, Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8
12/32
12/32
NCT06536374: Folate Study in Men With Advanced Prostate Cancer

Not yet recruiting
2
50
US
Trimethoprim Tablets
The University of Texas Health Science Center at San Antonio
Prostate Cancer
07/26
12/26
NCT04375813: Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention

Recruiting
2
166
US
eRapa, encapsulated rapamycin, Placebos
Rapamycin Holdings, Inc. dba Emtora Biosciences, National Cancer Institute (NCI)
Non-muscle Invasive Bladder Cancer
01/26
01/26
SNARE, NCT05593497: A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss

Recruiting
2
30
US
Capivasertib, abiraterone acetate
VA Office of Research and Development
High-Risk Prostate Cancer
05/27
08/27
NCT04597359: To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring

Recruiting
2
360
US, RoW
Placebo Administration, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Sinecatechins, Camellia sinensis Leaf Catechins, Kunecatechins, Polyphenon E, Polyphenon E TM, Veregen
ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI)
Prostate Carcinoma
12/32
12/32
ACCESS, NCT04404855: Antibiotic Selection Using Next Generation Sequencing vs Urine Culture

Completed
N/A
240
US
NGS + Antibiotic Recommendation, Standard of Care treatment
The University of Texas Health Science Center at San Antonio, MicroGen DX
Kidney Stone, Renal Stone, Infection, Bacterial
01/22
08/22
SEPTA, NCT04583072: Stockholm3 Validation Study in a Multi-Ethnic Cohort

Completed
N/A
2152
Canada, US
The Stockholm3 test, Diagnostic Test: Custom ancestry informative genetic markers
Karolinska Institutet, University of Illinois at Chicago, UroPartners, University of Chicago, Rush University Medical Center, Montefiore Medical Center, The University of Texas Health Science Center at San Antonio, Cook County Health & Hospitals System, Cook County Health, Stanford University, Northwestern Medicine, University of Southern California, University Health Network, Toronto, Urology Clinics of North Texas, LAC+USC Medical Center
Prostate Cancer (Diagnosis)
07/23
07/23
NCT03697148: Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer

Recruiting
N/A
852
US
Multiparametric Magnetic Resonance Imaging, MP-MRI, Multi-parametric MRI, Multiparametric MRI
ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI)
Prostate Carcinoma
12/24
08/25
PASS, NCT00756665: Prostate Active Surveillance Study

Recruiting
N/A
3000
Canada, US
University of Washington, Canary Foundation, Early Detection Research Network
Prostatic Neoplasms
09/29
09/32
NCT05334069: Collecting Blood Samples from Patients with and Without Cancer to Evaluate Tests for Early Cancer Detection

Recruiting
N/A
2000
US
Questionnaire Administration, Biospecimen Collection
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Ann Arbor Stage I Lymphoma, Ann Arbor Stage II Lymphoma, Ann Arbor Stage III Lymphoma, Ann Arbor Stage IV Lymphoma, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Gastroesophageal Junction Adenocarcinoma, Head and Neck Carcinoma, Hematopoietic and Lymphoid Cell Neoplasm, Invasive Breast Carcinoma, Kidney Carcinoma, Malignant Hepatobiliary Neoplasm, Malignant Solid Neoplasm, Melanoma, Muscle-Invasive Bladder Carcinoma, RISS Stage I Plasma Cell Myeloma, RISS Stage II Plasma Cell Myeloma, RISS Stage III Plasma Cell Myeloma, Sarcoma, Stage I Bladder Cancer AJCC V6 and V7, Stage I Breast Cancer AJCC V7, Stage I Colorectal Cancer AJCC V6 and V7, Stage I Esophageal Cancer AJCC V7, Stage I Gastric Cancer AJCC V7, Stage I Lung Cancer AJCC V7, Stage I Ovarian Cancer AJCC V6 and V7, Stage I Pancreatic Cancer AJCC V6 and V7, Stage I Prostate Cancer AJCC V7, Stage I Uterine Corpus Cancer AJCC V7, Stage II Bladder Cancer AJCC V6 and V7, Stage II Breast Cancer AJCC V6 and V7, Stage II Colorectal Cancer AJCC V7, Stage II Esophageal Cancer AJCC V7, Stage II Gastric Cancer AJCC V7, Stage II Lung Cancer AJCC V7, Stage II Ovarian Cancer AJCC V6 and V7, Stage II Pancreatic Cancer AJCC V6 and V7, Stage II Prostate Cancer AJCC V7, Stage II Uterine Corpus Cancer AJCC V7, Stage III Bladder Cancer AJCC V6 and V7, Stage III Breast Cancer AJCC V7, Stage III Colorectal Cancer AJCC V7, Stage III Esophageal Cancer AJCC V7, Stage III Gastric Cancer AJCC V7, Stage III Lung Cancer AJCC V7, Stage III Ovarian Cancer AJCC V6 and V7, Stage III Pancreatic Cancer AJCC V6 and V7, Stage III Prostate Cancer AJCC V7, Stage III Uterine Corpus Cancer AJCC V7, Stage IV Bladder Cancer AJCC V7, Stage IV Breast Cancer AJCC V6 and V7, Stage IV Colorectal Cancer AJCC V7, Stage IV Esophageal Cancer AJCC V7, Stage IV Gastric Cancer AJCC V7, Stage IV Lung Cancer AJCC V7, Stage IV Ovarian Cancer AJCC V6 and V7, Stage IV Pancreatic Cancer AJCC V6 and V7, Stage IV Prostate Cancer AJCC V7, Stage IV Uterine Corpus Cancer AJCC V7, Thyroid Gland Carcinoma
01/26
02/27
IMAGINED, NCT05882253: Prostate Cancer IMAGing IN Early Detection ( Trial)

Recruiting
N/A
225
US
Restricted Spectrum Imaging-Magnetic Resonance Imaging (RSI-MRI), On-Q Prostate
The University of Texas Health Science Center at San Antonio, National Cancer Institute (NCI)
Prostate Cancer
12/27
04/28
PATROL, NCT04472338: Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, Study

Recruiting
N/A
450
US
Biospecimen Collection, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration
University of Washington, National Cancer Institute (NCI), Canary Foundation, CureBRCA
Prostate Carcinoma
08/30
08/30
Tragus, Robin
NCT05894577: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast)

Completed
3
1453
US
Placebo, Montelukast
Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center
Covid19
07/23
01/24
NCT04885530: ACTIV-6: COVID-19 Study of Repurposed Medications

Completed
3
10956
US
Ivermectin, Ivermectin Tablets, Fluvoxamine, Fluvoxamine Maleate Tablets, Fluticasone, Fluticasone Furoate, Placebo, Montelukast, Metformin
Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center
Covid19
04/24
04/24
NCT06042855: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)

Completed
3
3214
US
Placebo, Metformin
Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center
Covid19
06/24
11/24
Weaver, Brandi
NCT06536374: Folate Study in Men With Advanced Prostate Cancer

Not yet recruiting
2
50
US
Trimethoprim Tablets
The University of Texas Health Science Center at San Antonio
Prostate Cancer
07/26
12/26
IMAGINED, NCT05882253: Prostate Cancer IMAGing IN Early Detection ( Trial)

Recruiting
N/A
225
US
Restricted Spectrum Imaging-Magnetic Resonance Imaging (RSI-MRI), On-Q Prostate
The University of Texas Health Science Center at San Antonio, National Cancer Institute (NCI)
Prostate Cancer
12/27
04/28
Horn, Sarah
CAMELOT, NCT05590637: Comparing Antipsychotic Medications in LBD Over Time

Recruiting
4
94
US
Pimavanserin, Nuplazid, Quetiapine, Seroquel
The University of Texas Health Science Center at San Antonio, Alzheimer's Association
Parkinson's Disease Psychosis, Dementia With Lewy Bodies
08/25
02/26
ACTIVATE, NCT05819359: Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD

Active, not recruiting
2
237
Europe, Canada, US
BIA 28-6156 10 mg, BIA 28-6156 60 mg, Placebo
Bial R&D Investments, S.A.
Parkinson's Disease
03/26
07/26
Guerra, Diana Anzueto
EMBARK, NCT04524390 / 2020-000974-22: Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai

Completed
2
75
Europe, US, RoW
Maralixibat, Formerly LUM001 and SHP625, Placebo
Mirum Pharmaceuticals, Inc.
Biliary Atresia
11/23
02/24
NCT05380401: Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants

Recruiting
N/A
328
US
Enfamil® DHA & ARA Supplement for Special Dietary Use, DHA/ARA Supplement
The University of Texas Health Science Center at San Antonio, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Premature
04/27
04/28
NCT04508348: Clinical Trial to Decrease Length of Stay in Infants With Neonatal Abstinence Syndrome With an Exclusive Human Milk Diet

Active, not recruiting
N/A
19
US
Human Milk, 100% Human Milk, Standard of Care, Mother's milk and/or formula
The University of Texas Health Science Center at San Antonio
Neonatal Abstinence Syndrome
03/25
03/25
Foster, Megan
NCT04601571: Confirming Feeding Tube Position Using CORTRAK

Withdrawn
N/A
75
US
CORTRAK Stylet, Feeding tube stylet
The University of Texas Health Science Center at San Antonio
Enteral Nutrition
06/25
06/26
Armijo, Veronica
NCT04621734: Retention of Nasoenteric Feeding Tubes in Pediatric Patients Using a Nasal Bridle

Completed
N/A
35
US
AMT BridlePro Device, Applied Medical Technology (AMT) BridlePro Device, Adhesive Tape, Tape
The University of Texas Health Science Center at San Antonio
Feeding Tube Complication
04/21
09/21
Armijo-Garcia, Veronica
ASCEND, NCT05388708: ARDS in Children and ECMO Initiation Strategies Impact on Neurodevelopment

Recruiting
N/A
550
Europe, Canada, US, RoW
ECMO support, PROSpect protocolized therapies
University of Michigan, National Heart, Lung, and Blood Institute (NHLBI)
Acute Respiratory Distress Syndrome, Extracorporeal Membrane Oxygenation
09/27
09/27
Zelle, Boris
NCT05971173: Nutritional Optimization and Bone Health Management for Older Adults Undergoing Hip Fracture Surgery

Active, not recruiting
1
40
US
Juven, Conditionally essential amino acids, Centrum Silver 50+, Multivitamin/multimineral
The University of Texas Health Science Center at San Antonio, National Institute on Aging (NIA)
Hip Fractures
12/24
12/25
PEGASUS, NCT05523635: Post Market Clinical Evaluation of Gamma 4

Recruiting
N/A
100
US
Gamma4 Nailing System
Stryker Trauma and Extremities
Femoral Fracture
06/25
06/25
Silverglade, Jonah
NCT05380401: Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants

Recruiting
N/A
328
US
Enfamil® DHA & ARA Supplement for Special Dietary Use, DHA/ARA Supplement
The University of Texas Health Science Center at San Antonio, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Premature
04/27
04/28

Download Options